← Back to Search

Exercise and Prehabilitation for Kidney Failure

N/A
Waitlist Available
Led By Christopher Nguan, MD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to 1 week prior to renal transplantation. again, change from 1 month post transplant to 6 month post transplant.
Awards & highlights

Study Summary

This trial is testing whether an exercise intervention prior to kidney transplantation can improve post-operative outcomes. The study will look at outcomes including walking speed, strength, endurance, quality of life and fatigue.

Eligible Conditions
  • Kidney Failure

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from 1 week following kidney transplant to 30 and 90 days post operatively.
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from 1 week following kidney transplant to 30 and 90 days post operatively. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in 30-second timed sit to stand.
Change in 6-minute walk test (6-MWT).
Change in Fried Frailty Score.
+6 more
Secondary outcome measures
Participant adherence to a tailored home-based exercise program.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Exercise GroupExperimental Treatment1 Intervention
All participants who are allocated to the exercise group will be asked to complete 4-5 days per week of mixed modality exercise incorporating aerobic, resistance, and flexibility training. The exercise intervention is prescribed based on the FITT principle: frequency, intensity, time and type. The 10-point Rating of Perceived Exertion (RPE) scale, which has been well correlated to target HR levels, will be used to monitor exercise intensity levels throughout the intervention, with participants instructed to maintain their intensity level at 3-5 during exercise sessions. Participant progression will be individualized and based on their subjective perceived intensity level using the RPE scale. In person instruction, from a member of the research team with standard first aid and CPR-C training, and an instructional handout and exercise log will be provided, as well as exercise resistance bands to perform resistance exercises.
Group II: Control GroupActive Control1 Intervention
This will consist of regular care, which is standard procedure.

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,413 Previous Clinical Trials
2,466,811 Total Patients Enrolled
Christopher Nguan, MDPrincipal InvestigatorUniversity of British Columbia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~27 spots leftby Apr 2025